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ABSTRACT 
Regulatory compliance with international regulations is the first step towards international presence 
in the cosmetic market. The cosmetic industry, from manufacturers to traders, must be able to adapt 
to a constantly changing framework. Even if there is a tendency to unite cosmetic legislations across 
countries, enough differences remain and may result in lack of compliance and product recalls or 
sanctions. In this review, the legislative evolution in Europe for cosmetic products is analysed, and 
then compared to five other countries in order to see what common ground they share and what are 
the differences that set them apart. Product classification, product control and composition stand out 
as the three divergent elements in international compliance that can constitute barriers to trade. 
Among the common elements, good manufacturing practices guidelines and product labelling are 
similar from country to country, albeit with some slight changes. 
RESUMEN 
Establecer el nivel de cumplimiento con las regulaciones internacionales es el primer paso para 
conseguir una presencia internacional de un producto cosmético. La industria cosmética, tanto 
fabricantes como comerciantes, deben ser capaces de adaptarse a unos requisitos que se encuentran 
en constante transición. A pesar de que existe una tendencia generalizada de convergencia en 
algunos aspectos, las diferencias siguen siendo lo suficientemente importantes como para resultar en 
productos no cumplidores que pueden llevar a retiradas de mercado o incluso sanciones. En esta 
revisión, se ha analizado la evolución de la legislación Europea en tema de cosméticos, y luego se ha 
establecido una comparativa con otros cinco países con el objetivo de determinar las similitudes 
existentes y qué características son las que los diferencian. La clasificación de productos cosméticos, 
la regularización y control de los mismos y su composición son tres de los temas que presentan una 
mayor divergencia a nivel internacional. Otros aspectos como el cumplimiento de las buenas 
prácticas de Fabricación y etiquetado se mantienen relativamente constantes entre países con solo 
algunos cambios menores. 
ABBREVIATIONS 
INCI – International Nomenclature of 
Cosmetic Ingredients 
PAO – Period After Opening 
CMR – Carcinogenic, Mutagenic, Reprotoxic 
GMP – Good Manufacturing Practices 
PIF – Product Information File 
FDA – Food and Drug Administration 
OTC – Over-the-counter 
CFDA – Chinese Food and Drug 
Administration 
MUCAP – Maximum Used Concentration in 
Approved Product 
SFDA – Saudi Food and Drug Administration 
CAP – Conformity Assessment Program 
CAN – Comunidad Andina de Naciones 
INVIMA – Instituto de Vigilancia de 
Medicamentos y Alimentos 
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1. INTRODUCTION 
As the world seemingly strives to become a more globalised and better connected environment, 
where new trade agreements are signed between nations and the internet presenting itself as a 
powerful tool to reach the end consumer, it becomes increasingly important to understand that 
cosmetic products are part of a regulatory landscape that is far from homogenous. In fact, significant 
differences between cosmetic legislations and technical requirements can be a source of major 
headaches for companies who wish to begin an international venture. While some countries have 
decided that cosmetics need to be legislated in order to protect both the health and interests of the 
consumer, and have accordingly set up a regulatory standard against which all the industry must be 
measured, other countries have not yet reached the same level. Furthermore, this is also reflected in 
the nature of the authority in charge of the control and market surveillance of cosmetics that are sold 
or imported into a country; while it is usually the health authorities that assume this function, some 
countries have assigned this to the commerce or industry administration, to the customs department 
or the local standardisation departments. 
In order to gain a perspective in economic terms, the estimated international market size in 2001 for 
the cosmetic, toiletry and fragrance industry was $124 billion (€110 billion) (1). This value, 
according to the latest predictions, will have more than doubled by 2017, by which time it will have 
reached a global value of $265 billion (€236 billion) (2). This growth has been supported by an 
emerging Eastern market, in which countries such as China, Japan or South Korea have been steadily 
increasing in value from both an economic and scientific progress standpoint. Well established 
markets have also continued growing at a steady pace, and Spain has its own place in these figures. 
Currently estimated to be worth €6.5 billion making it the 5th within the European Union, it holds 6th 
position worldwide in export of cosmetic goods, with a total revenue of €2.6 billion (3). 
With the current size of the cosmetic industry and its perspectives of growth and advancement in the 
following years, the regulatory status will be in constant change trying to keep up with the progress 
being made. However, there is much to learn from the current situation, and it is interesting to be 
able to provide a snapshot in order to better understand not only what it has to offer at this moment in 
time but also its limitations.   
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2. OBJECTIVES AND METHODOLOGY 
This review aims to provide a general understanding of the current international regulatory 
framework in place for the design, production and commercial distribution of cosmetics and how 
legislative differences between countries relate to the cosmetic industry in practical terms.  
With such a complex international legislative framework, analysing and reviewing every single piece 
of legislation on the statute books would not be viable. Thus, the aim is to achieve a general vision 
by examining a cross-section in which all parts may be represented and in which there is enough 
variety and examples of what the differences are and their implications. In order to achieve a valid 
cross-section, the perspective that will be employed will follow a middle-out criteria, which can be 
broken down into two points: firstly, the analysis of current and past legislation in Spain and in the 
European Union, and secondly, the relationship between these regulations and other significant laws 
in place in other countries or international associations. 
The current legislation in place within the European Union, which all member states have to comply 
with, is a standard which many countries have chosen to either accept, include or follow in their 
respective regulations, making it a valid starting point from which measure the scope of other 
legislations. Furthermore, by examining the evolution of cosmetics legislation in Europe we can also 
gain some insight into what might happen in the future on a global scale.  
From the European Union, we move outwards to examine the legislative structures of  other 
countries. These countries have been selected both for their geographical or political location, 
meaning that they are members of an international cooperation agreement with common legislations, 
such as the EU, and because they have a certain level of influence over adjoining countries, with 
their legislations being used as a common standard, explicitly or not. The countries that have been 
selected are five in total: the United States of America (the USA), China, Saudi Arabia, Colombia 
and the Philippines. As to the individual reasons why these countries have been selected, we can 
argue the following: the USA is a clear choice because of its economic dimension and influence over 
other countries in as regards to normative standards; China is an emerging market and also an 
economic force to be reckoned with, offering a very interesting counterpoint as to the legislation of 
cosmetic products that will serve as contrast; Saudi Arabia is also an emerging market with a very 
important niche for luxury cosmetics, and it provides a window into what regulations may be like in 
Islamic countries where cultural elements might play an important part; finally, Colombia and the 
Philippines have not been chosen for the novelty factor, they do not introduce crucial elements of 
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differentiation, but they are representatives of the international associations they belong to and offer 
a perspective of the geographical areas they belong to. 
To sum up this section, the middle-out perspective comes from first reflecting on the European 
legislation and its recent evolution, and comparing the present regulatory status of the European 
Community to the corresponding international standards over the selected countries. To be able to 
offer an exact and truthful review, the primary sources of information should be, when available, the 
original legal texts published by the relevant authorities, official or international standard documents 
or official guidelines. The last item, the official guidelines, although they might not carry the same 
legal weight that a law or regulatory text does, are documents published by the relevant authorities to 
explain the requirements and minimum expectations of compliance. Dealing with a language barrier, 
sometimes it is hard to obtain primary sources of information. Where these are lacking, official 
translations will be the best alternative to the original, and these not being available, we will refer to 
publications done by experts or relevant figures in the cosmetic sector. 
Finally, we will conclude with the examination of two practical cases: we will present two marketed 
formulas for cosmetic products that are compliant with the European legislation, a face moisturising 
cream and a sunscreen. We will then explore what the technical requirements would be in order to be 
able to export these products and if they are fully suitable for sale in other countries. 
3. RESULTS 
The result of the comparative work has been presented for better understanding in the form of tables 
which allow for an initial perspective on the subject and to be able to discern divergent aspects at a 
glance. 
Firstly, a table consisting on the comparative analysis obtained through examination of the previous 
European Directive on cosmetic products and the current European Regulation which is presently in 
force. This table is presented as Table 1 and contains specific elements of the legal texts that have 
been identified in order to break down these into sections with actual comparative value. 
Secondly, following the same criteria, the comparative analysis has been extended from the 
European Regulation onto the international standards with the results being featured in Figure 2, 
consisting on a more extensive comparative table including the same elements that had been 
identified in the first examination. 
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Table 1, comparison of the main aspects included in the European cosmetics legislation. 
NORMATIVE DIRECTIVE 76/768/EEC REGULATION EC 1223/2009 
DEFINITION A ‘cosmetic product’ shall mean any 
substance or mixture intended to be 
placed in contact with the various 
external parts of the human body 
(epidermis, hair system, nails, lips 
and the external genital organs) or 
with the teeth and the mucous 
membranes of the oral cavity with a 
view exclusively or mainly to 
cleaning them, perfuming them, 
changing their appearance and/or 
correcting body odours and/or 
protecting them or keeping them in 
good condition. 
A “cosmetic product” means any 
substance or mixture intended to be 
placed in contact with the external 
parts of the human body (epidermis, 
hair system, nails, lips and external 
genital organs) or with the teeth and 
the mucous membranes of the oral 
cavity with a view exclusively or 
mainly to cleaning them, perfuming 
them, changing their appearance, 
protecting them, keeping them in 
good condition or correcting body 
odours. 
PRODUCT 
CONTROL 
As stated in Article 2, it is the 
responsibility of each of the member 
states to control that the cosmetic 
products which access the market are 
compliant with the Directive. 
The cosmetic product is under a 
“Responsible person” and the 
authorities must be notified previously 
to the product entering the market. 
Detailed obligations for responsible 
person and distributor. 
INGREDIENTS 
AND 
COMPOSITION 
A comprehensive list of substances 
has been set in order to restrict, 
control or allow the use of certain 
substances, which have been 
included as annexes of the Directive.  
The annexes detailing the composition 
have been maintained and updated 
accordingly, prohibiting, restricting or 
allowing certain ingredients from 
being part of a cosmetic product. 
There is additional text regarding 
CMR substances and Nanomaterials. 
LABELLING 
AND 
MARKING 
Label control is given to the control 
of the authorities of each member 
state. However, the items that must 
appear have been listed: 
- Name and address of the responsible 
person. 
- Nominal content 
- Date of minimum durability or PAO 
- Particular precautions 
- Batch number 
- Function of the product unless clear 
from presentation 
- Ingredient list 
Labelling control becomes a part of 
the notification process. And any 
changes have to be submitted. The 
items that must appear: 
- Name and address of the responsible 
person. 
- Nominal content 
- Date of minimum durability or PAO 
- Particular precautions 
- Batch number 
- Function of the product unless clear 
from presentation 
- Ingredient list. 
GMP The manufacturing method must 
comply with the Good 
Manufacturing Practices laid down 
on the corresponding guide. 
The manufacturing process must 
follow the approved Good 
Manufacturing Practices, ISO 22716. 
 
ANIMAL 
TESTING 
A ban is introduced on non-approved 
animal testing being carried out both 
on ingredients and finished product. 
A complete ban is set for cosmetics 
which have been tested on animal, be 
it the finished product or their 
ingredients. 
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Table 2. Comparative table of the identified key aspects throughout the international framework. 
COUNTRY EUROPE UNITED 
STATES 
CHINA SAUDI 
ARABIA 
COLOMBIA PHILIPPINES 
DEFINITION A “cosmetic 
product” means 
any substance or 
mixture intended 
to be placed in 
contact with the 
external parts of 
the human body 
(epidermis, hair 
system, nails, lips 
and external 
genital organs) or 
with the teeth and 
the mucous 
membranes of the 
oral cavity with a 
view exclusively 
or mainly to 
cleaning them, 
perfuming them, 
changing their 
appearance, 
protecting them, 
keeping them in 
good condition or 
correcting body 
odours. 
Articles intended 
to be rubbed 
poured, sprinkled, 
or sprayed on, 
introduced into, or 
otherwise applied 
to the human body 
or any part thereof 
for cleansing, 
beautifying, 
promoting 
attractiveness, or 
altering the 
appearance and 
articles intended 
for use as a 
component of such 
articles. 
Defined as daily 
used industrial 
chemicals which 
can be spread on 
the outer surface 
of the human 
body (skin, hairs, 
nails, lips, etc.) 
for the purpose of 
cleaning, 
deodorizing, 
providing skin 
care, beauty and 
make-up, by way 
of smearing, 
spraying or other 
chemical means. 
“any substance or 
preparation 
intended to be 
placed in contact 
with the various 
external parts of 
the human body 
(epidermis, hair 
system, nails, 
lips, and external 
genital organs) or 
with the teeth and 
the mucous 
membranes of the 
oral cavity with a 
view exclusively 
or mainly to 
cleaning them, 
perfuming them, 
changing their 
appearance 
and/or protecting 
them or keeping 
them in good 
condition”. 
“any substance or 
formulation for 
local application 
intended for use on 
the different 
superficial areas of 
the human body: 
epidermis, hair, 
nails, lips and 
external genital 
organs or on the 
teeth or mucous 
membranes, with 
the aim to clean, 
perfume, change 
appearance, protect 
or maintain them in 
good condition and 
prevent or correct 
body odours.” 
 
“any substance or 
preparation intended 
to be placed in 
contact with the 
various external parts 
of the human body 
(epidermis, hair 
system, nails, lips and 
external genital 
organs) or with the 
teeth and the mucous 
membranes of the 
oral cavity with a 
view exclusively or 
mainly to cleaning 
them, perfuming 
them, changing their 
appearance and/or 
correcting body 
odours and/or 
correcting them or 
keeping them in good 
condition” 
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COUNTRY EUROPE UNITED 
STATES 
CHINA SAUDI ARABIA COLOMBIA PHILIPPINES 
PRODUCT 
CONTROL 
The cosmetic 
product is under a 
“Responsible 
person” and the 
authorities must 
be notified 
previously to the 
product entering 
the market. 
Detailed 
obligations for 
responsible 
person and 
distributor. 
Cosmetic 
products can be 
voluntarily 
registered with 
the FDA. 
Imported 
cosmetics are 
examined upon 
entry. 
General use 
cosmetics have 
to be 
registered, 
while special-
use cosmetics 
must have an 
administrative 
authorisation 
from the 
SFDA. 
A notification system 
is being implemented 
for local and foreign 
manufacturers and 
products. For imports, 
there is also a 
Conformity 
Assessment Program. 
The notification 
system is the method 
of product control. 
Local manufacturers 
and importers must 
notify the products 
they intend to sell 
and await for 
authorisation. 
Product control is 
exercised 
through cosmetic 
notification to the 
Philippines FDA.  
Approval is 
issued by 
authorities as to 
market access is 
granted. 
INGREDIENTS 
AND 
COMPOSITION 
The annexes 
detailing the 
composition have 
been maintained 
and updated 
accordingly, 
prohibiting, 
restricting or 
allowing certain 
ingredients from 
being part of a 
cosmetic product. 
There is 
additional text 
regarding CMR 
substances and 
Nanomaterials. 
The FDA has 
prohibited the use 
of 12 ingredients. 
The rest are to be 
used only when 
considered safe 
under normal use. 
Liability lies with 
the person 
responsible for 
the marketing of 
the cosmetic. 
Nanomaterials 
are allowed, but 
FDA encourages 
previous 
knowledge 
CFDA 
regulates 
cosmetic 
composition 
through a 
positive list of 
approved 
ingredients, 
IECIC. 
New 
ingredients can 
be used but 
need to be 
submitted for 
registering. 
Adapted version of 
the composition tables 
included in the 
Directive 76/768/EEC 
in which a few 
ingredients have been 
changed. Total 
prohibition on pork 
derivatives. Special 
conditions for 
inclusion of alcohol as 
an ingredient. 
Official recognition 
of international 
ingredient standards: 
- USFDA 
- CTFA 
- Cosmetics 
Europe 
- EU Directives 
There is express 
indication of the 
acceptance of the 
European 
Cosmetic 
Ingredient 
Listings included 
in the Cosmetic 
Directive 
76/768/EEC.  
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COUNTRY EUROPE UNITED 
STATES 
CHINA SAUDI ARABIA COLOMBIA PHILIPPINES 
LABELLING 
AND 
MARKING 
Labelling control 
becomes a part of 
the notification 
process. The items 
that must appear: 
- Name and 
address of the 
responsible 
person. 
- Nominal 
content 
- Date of 
minimum 
durability or 
PAO. 
- Particular 
precautions 
- Batch number 
- Function of the 
product  
- Ingredient list. 
Claims are subject 
to control. 
The label must 
include: 
- Name and 
address of 
business 
- Net content 
- Any 
instructions 
deemed 
necessary so 
as to not pose 
any risk.  
 
A misbranded 
product is the 
one bearing an 
incorrect label 
for non-inclusion 
of relevant 
information or 
for misleading. 
 
The labelling 
requirements are 
as follows: 
- Product name 
- Net content 
- Country of 
origin 
- Name and 
address of 
manufacturer 
- Ingredient list 
- Warning 
statements 
and 
instructions. 
- Name and 
address of the 
importer 
- Licence 
number 
- Shelf life 
- Batch number 
Labelling 
requirements include: 
- Name and address 
of 
manufacturer/sup
plier 
- Any particular 
precaution 
according to the 
composition. (can 
be in English) 
- Batch number 
- Function* 
- Expiry date or 
PAO 
- Net content 
- Country of origin 
 
For products 
containing alcohol: 
SASO 582/2000 
The labelling 
requirements are: 
- Product name 
- Net content 
- Country of 
origin 
- Name and 
address of 
manufacturer 
- Ingredient list 
- Warning 
statements 
and 
instructions. 
- Name and 
address of the 
importer 
- Licence 
number 
- Shelf life 
- Batch number 
- NSO number 
Labels must 
include the 
following: 
- Product name 
- Function 
- Instructions 
for use 
- Full ingredient 
listing 
- Country of 
manufacture 
- Name and 
address of the 
company/pers
on responsible 
- Net content 
- Batch number 
- Expiry date or 
PAO. 
- Special 
precautions 
GMP The manufacturing 
process must 
follow the 
approved Good 
Manufacturing 
Practices, ISO 
22716. 
A Draft GMP 
Guide has been 
issued by the 
FDA. 
Compliance is 
“advised”. 
A document has 
been published 
with GMP-like 
guidance for 
manufacturers 
No direct reference to 
published GMP 
guidelines. 
Acceptance of the 
international 
standards in GMP. 
CAN GMP guide 
has been 
published and 
transposed . 
ASEAN GMP 
guidelines and 
answer to 
industry. 
Recognition of 
international 
standards. 
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COUNTRY EUROPE UNITED 
STATES 
CHINA SAUDI ARABIA COLOMBIA PHILIPPINES 
ANIMAL 
TESTING 
A complete ban is 
set for cosmetics 
which have been 
tested on animal, be 
it the finished 
product or their 
ingredients. 
 
The FDA does not 
hold a determinant 
position regarding 
animal testing. 
Neither in favour 
nor against, safety 
comes first. 
Animal testing is 
compulsory for all 
imported 
cosmetics and all 
domestic special-
use cosmetics. 
There is no 
reference to 
animal testing. 
Product safety is 
to be assured. 
There is no 
reference to any 
ban being in place 
for animal testing 
in cosmetics 
There is no ban in 
place for animal 
testing. Official 
position not stated.  
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4. DISCUSSION 
4.1. EUROPEAN COSMETIC LEGISLATION: 
To appreciate progress there is an essential need to define a reference starting point. To understand 
the latest and current legislation that guides and determines both the industry and the end cosmetic 
product, we will look back at its predecessor.  
In Europe, the Directive 76/768/EEC (4) came into force in the year 1976, with a two year margin 
for member states to transpose this directive. Although several amendments were introduced, this 
regulation stayed in place until 2013, when the new European Directive 1223/2009 replaced the old 
one introducing several important changes. 
In this section, the key elements of the old cosmetics directive that have been identified will be 
examined by themselves, and also how they have been updated in the new regulation to adapt to the 
changes that have occurred in the cosmetic world since. This comparison has been represented in 
Table 1, in which both European directives have been divided into its parts, summed up and set side 
by side so as to better appreciate the existing differences. Following, the comparative table is 
explained in further detail and the differences are explained. 
4.1.1. The old Directive 76/768/EEC 
Despite having been published in 1976, this legislation continues to be very much present nowadays. 
It stays on in the direct or indirect influence it has had over the regulatory status of cosmetics all over 
the world; whether it is as reference material or as a direct transposition or acceptance of the 
standards that are set in this directive, many countries have assimilated it into their legal structure. 
At the centre of the directive stands the first element included in Table 1: the definition of what 
constitutes a cosmetic; “ 
“cosmetic product shall mean any substance or mixture intended to be placed in contact with the 
various external parts of the human body (epidermis, hair system, nails, lips and external genital 
organs) or with the teeth and the mucous membranes of the oral cavity with a view exclusively or 
mainly to cleaning them, perfuming them changing their appearance and/or correcting body odours 
and/or protecting them or keeping them in good condition.” (4) 
This directive gives a positive definition by including three different characteristics: 
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- Cosmetic product: a cosmetic can not only be a mixture, which is what we may traditionally 
regard it as, but it can also be a single ingredient.   
- Area of application: a list of areas where a cosmetic product can be applied or used is given, 
in which all areas can be considered as external in so much as mucous membranes can be 
considered as outwardly. 
- Function: arguably the most interesting part of the definition as it separates the cosmetic 
product from any other kind of products based on its intended use. 
Together, these characteristics clearly define what constitutes a cosmetic product and allows for the 
classification into different categories according to one or more of these characteristics. A 
comprehensive list of this categorization is included in the actual directive so as to better guide the 
industry towards achieving compliance. 
Following the product criteria of the definition, for any cosmetic, be it a single substance or mixture, 
the ingredients that can be included into its composition have been incorporated into the directive. 
Due to the vast and ever-growing amount of ingredients being discovered, designed or repurposed, a 
complete positive list of ingredients is not manageable from a regulatory point of view. Instead, 
several lists have been included into the annexes of this directive that together aim to control the 
safety of the cosmetic product for the consumer population. The lists are as follows: 
- Prohibited substances: including all substances which cannot be part of the composition of a 
cosmetic product. This list constitutes Annex II of the cosmetics directive. 
- Regulated substances: composed of several lists in which restrictions are set for certain 
allowed substances in regards to the concentration in the finished product relating also to 
their function. The lists include: 
• Substances included in Annex III 
• Colouring agents included in Annex IV. 
• Preservatives included in Annex VI 
• UV filters included in Annex VII 
All ingredients which are deliberately introduced into a cosmetic product must appear in INCI 
nomenclature on the label as per Article 6 of the regulation, in decreasing order of concentration for 
those over 1% and in any order for those under 1%. For the particular cases of perfumes the word 
“parfum” or “fragrance” is accepted, and in colorants, the code by which they are known. 
T h e  i n t e r n a t i o n a l  c o s m e t i c  r e g u l a t o r y  f r a m e w o r k                P a g e  | 13 
 
This leads us to the next part of the legislative text, in which the labelling requirements are set. For 
every cosmetic product the following items must appear on the label:  
- Name and address of the manufacturer or responsible person. As if hidden, this simple 
sentence has a deep significance within the regulation. It introduces the concept or 
“responsibility”. For any cosmetic product in the market there is, according to this, a person 
who will and must answer to any issues derived from the cosmetic product. This 
responsibility could also turn into liability if the cosmetic product is not only found to be non-
compliant with the directive, but also if it poses a health risk for the consumer. 
- The nominal content at the time of packaging, in weight of volume. 
- The minimum durability date of the product. This can appear as an actual date, as a 
month/year or, for products with a shelf life of over 30 months, as what is called a PAO 
(period after opening), which is an indication of the period of time in which the product can 
be used without harm to the consumer.  
- Particular precautions, which may have to do with the presence of a certain ingredient, such 
as the ones in the regulated lists, a specific presentation or the packaging.  
- The batch number of manufacture. This assures traceability of the finished product and is 
deeply related to the exercise of good manufacturing practices. 
- The function of the product, unless it is clear from the presentation. 
- The list of ingredients, as previously mentioned. 
The Directive itself clearly indicates that each member state must assure the implementation of the 
standards provided in it, and it does so in Article 3, in which it grants each of these members the 
supervision over the market control of cosmetics in their country, and full compliance of the industry 
and final products. Furthermore, in Article 7a the directive gives the instruction that the competent 
authority must be notified of the manufacturing of the cosmetic product and that a certain amount of 
information regarding the cosmetic product must be kept available at the address stated as the 
responsible person’s address. Being a process left to the disposition of each country, places like 
Spain adopted a Registration System, by which the product was revised by the authorities and once it 
was deemed to be compliant with the directive, it would then be authorised for commercial 
distribution.  
A part of the information to be kept and to be reviewed by the authorities is a GMP assessment, in 
which the method of production must be explained and it must follow the good manufacturing 
practices. 
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Last but not least, a matter of much ethical debate, animal testing. In the old directive, animal testing 
was not expressly banned, but rather adjusted itself to the good laboratory practices. Animal testing 
should be limited to practices and tests approved by the health authorities and carried out in the same 
manner.  
4.1.2. The new Regulation EC 1223/2009 
After the new Regulation EC 1223/2009 (5) was entered into force in 2009, it fully replaced the old 
Directive 76/768/EEC from 2013. Issued as a Regulation, member states do not need to exercise a 
transposition of the actual Regulation or its contents, further helping the harmonization process by 
direct application of the European legal text. With it, some crucial and significant changes were 
made to the cosmetic sector with the aim of making compliance easier and safer for the consumer at 
the same time. In this section we will highlight these changes and discuss their implications in order 
to grasp an understanding of the current framework set around cosmetic products and its industry. 
Following the same order as with the previous directive, the new regulation does not introduce any 
significant changes to the definition of the cosmetic product. It still includes the triple positive 
definition of composition, area of application and function. The fact that the definition has not been 
changed means that there has been no need for a product reclassification which would entail that 
certain products would be under the scope of another regulation. 
Regarding the composition, another thing that has remained is the classification of cosmetic 
ingredients into corresponding lists according to whether they are prohibited, regulated based on 
maximum allowed concentration and function, and allowed substances for specific functions, like 
colouring agents or UV filters. However, there are two new additions to the ingredient 
considerations: CMR substances and Nanomaterials. CMR substances are those that can be 
carcinogenic, mutagenic or reprotoxic when used, and their inclusion is initially prohibited. 
Exceptions could however be made if the scientific reviews deem it safe for human use in cosmetic 
form and there are no possible alternatives to their use. In the case of nanomaterials, the 
corresponding authorities need to be expressly notified of their presence in the cosmetic product 
formula and enough data must be available that ensures its safety in human cosmetics. They must 
also be listed as such in the label so as to inform the consumer of their presence and allow for an 
informed decision.  
No significant changes have been made to the minimum labelling requirements either, the 
information to be included in it remains the same, but the description and indications given in the 
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Regulation are clearer and more elaborate. As before, the language in which the label must bear the 
relevant information must be determined by the member states, although it is generally accepted that 
the label must be in the main language of each country in which the cosmetic product wants to be 
marketed.  While all this has not varied much, there is one element that is becoming increasingly 
important in the cosmetic industry which is featured in this Regulation in its Article 20, Product 
claims1. This article clearly states that there must be no kind of implication that the cosmetic product 
bearing the claims has characteristics or functions that they do not have. This concept is further 
explored in the Commission Regulation (EU) No 655/2013 of 10 July 2013 (6), dedicated to 
cosmetic claims in which, among other things, it states that claims are an information tool for the end 
consumer, and as such, any claim that is included must be proved or substantiated and based on six 
distinct principles: legal compliance, truthfulness, evidential support, honesty, fairness and informed 
decision-making. In this way, product assertions are regulated specifically from a health authority 
standpoint and not only from a publicity and advertisement point. 
Product control in the new Regulation is now not only a question for each member of the European 
Union to decide upon. Rather, responsibilities have been shared out and now each part bears an equal 
load in regards to product compliance with the Regulation. The figure of the Responsible Person is 
still present, but the concept has been slightly expanded to include the preparation and custody of 
what has been deemed a “product information file” or PIF. This PIF is similar to the information 
dossier that needed to be done under the old Directive 76/768, and it includes a safety assessment 
report as a main part of it. This PIF must be kept at the premises given for the responsible person and 
be available upon request of the health authorities for a period of 10 years after the last batch has 
been placed in the market. The next level of control, the one exercised by the corresponding 
authority of each member state has also been shifted from the market authorisation, which has 
disappeared, to a market surveillance scheme as described in Article 22, where it gives each country 
the right and responsibility to check the products that are being sold in their territory through the PIF 
and any testing they deem necessary, as well as monitoring compliance with the principles of good 
manufacturing practices. Lastly, the now extinct market authorisation (which was basically a 
registration process) has been substituted by a Notification scheme by which, through electronic 
means, the responsible person or notifier shall submit a certain degree of information such as the 
category, name and address of the responsible person, member state in which it was first placed in 
the market, etc. All this information is enough to identify without a shadow of a doubt the product, 
the responsible person and the degree of health-relevance that the product might carry.  
1 Claim: (noun) Assertion that something is true. Oxford Dictionary. 
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In line with what we just reviewed, GMP compliance is a key issue in this regulation. The production 
method must be described in the PIF, and it should reflect the GMP principles. As seen, inspections 
can be carried out by the authorities of the member states to assure that the facilities and processes 
are adapted to the GMP indications. According to the relevant article of the Regulation, Article 8, 
these GMP shall be drawn from the corresponding harmonised standard, which is to mean, that ISO 
22716 is the reference guide to GMP implementation and assessment, and it is this standard by 
which all manufacturers and distributors must abide by in their activity. Since it is an international 
standard, local health authorities cannot certify compliance to the ISO 22716, which can be done 
through private entities, but it is expected upon inspection to be able to prove full observance and 
when found not to, there could be liability or administrative repercussions. 
Finally, and as the first regulation to introduce this worldwide, this directive expressly bans all 
animal testing from cosmetic products and ingredients, and for any testing to be done within the 
European Union. Instead, valid in vitro methods are to be used for product and ingredient 
assessment. All previous ingredients and products that in order to fulfil compliance with the previous 
Directive had carried out animal testing, could still be placed in the market, however, no further 
testing can be done. All new ingredients and products must be sure to ascribe to the valid alternative 
testing methods in order to complete the respective Material Safety Data Sheets and Safety 
Evaluation Reports.  
It is clear that both the old European Directive and the new European Regulation are intricate texts 
which present the opportunity for a more in-depth review and examination of the repercussions, 
interpretations and implications of all the wording set in place. However, the key points which arise 
when examining any regulatory text have been identified, weighed and compared in order to give the 
intended bird’s-eye view, which will be necessary in order to be able to envision a global regulatory 
framework in place.  
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4.2. INTERNATIONAL COSMETIC LEGISLATION 
In order to examine the international cosmetics legislation we have defined a starting point in the EU 
Regulation 1223/2009. From here, comparisons can be drawn and other legal mechanisms and texts 
better understood. Because of the impracticality of examining each and every legislation in every 
country, a representative selection has been drawn. As stated previously, the countries have been 
selected for various reasons: their political area of influence, the relevance of their regulatory stance 
or the membership to an international community with shared normative. The following five 
countries fit into one or more of these reasons, and at the same time offer enough diversity as to 
consider the selection representative. Also, for the sake of increasing the comparative value of the 
regulation analysis, the main focus will be set on the key elements that had been identified in the 
previous section during the review of the European normatives. A comparative table has been drawn 
which includes an overview of this section, included in the Results section of this review. Next, we 
will explore the comparative results by further examining the differences that have appeared. 
4.2.1. United States of America 
The political influence of the USA over neighbouring countries and worldwide is beyond any doubt. 
However, the regulatory area of influence is equally important as far as cosmetics legislation goes. 
Citation of the regulatory text or standards is not uncommon when consulting different legal texts 
form all over the world, and although it is usually with respect to specific aspects such as 
composition restrictions. However, this is not the only reason as to why the USA has been chosen for 
this comparison. This country offers a significantly different regulation and compliance procedure to 
the EU, and is a perfect example of a contrasting outlook.  
The Food and Drug Administration (FDA) is the health authority in charge of the regulation and 
control of cosmetic products. Through the regulatory texts and guidance documents which interpret 
laws, the FDA sets the standards which are to be followed and exercises its own kind of control over 
compliance with them. 
According to the Federal Food, Drug, and Cosmetic Act (FD&C), cosmetics are “articles intended to 
be rubbed, poured, sprinkled, or sprayed on, introduced into, or otherwise applied to the human 
body or any part thereof for cleansing, beautifying, promoting attractiveness, or altering their 
appearance, and articles intended for use as a component of any such articles” (7). If we break this 
down, we can see that a heavy emphasis is made to incorporate into the definition of a cosmetic the 
different application methods and to make sure that all are covered within. This comes as a contrast 
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to the European Regulation in which the stress was made to define a cosmetic through area of 
application rather than methods. Secondly and probably most importantly are the functions which 
define a cosmetic. In the US regulation, the definition does not include two key terms: “protecting” 
and “correcting”. While it might not look like a very relevant omission, it is the source of great 
concern for those in the industry willing to import or manufacture inside the US. The implications 
that these two words have are bigger than one might expect. The absence of the first of these terms, 
protecting, directly affects products such as sunscreen preparations, which have a function of 
protecting the skin against UVA and UVB radiation. In the case of the second term, correcting, it can 
relate to antiperspirants, for which the function would be to correct excessive sweating. In both these 
cases, the products mentioned would not be considered as a cosmetic product. Better said, they 
would be doubly classified as a cosmetic and an over-the-counter (OTC) drug at the same time and 
as such would have to be compliant to both the cosmetic and OTC drug regulations. Other products 
such as anti-dandruff shampoos also have this double classification because of its dual function, both 
as a tool to clean hair and to treat dandruff conditions (treating being an element of the definition of a 
drug) (8). 
Regarding product and market control, the FDA does not pre-approve a cosmetic product for its 
marketing and distribution. Compliance with the standards and regulations lies within the responsible 
person, be it a physical or judicial, for the product being on the market. However, the fact that no 
pre-market approval exists does not mean that the FDA exercises no control, but rather that products 
on the market can be tested or examined and anything that might be a risk to human health will have 
the corresponding consequences of product withdrawal and possibly administrative sanctions. For 
imported products, these are examined upon entry to the US, and deemed as fit to be granted access 
or an Notice of Action or Warning Letters will be issued in order to address any non-compliance that 
might have arisen (9) (10) . 
There is, nonetheless, a Voluntary Registration Program (VCRP) to which products and 
manufacturers can endorse. Only cosmetic products which are already on the market can be 
registered, and it does not grant an approval by the authorities, but rather it is a means for the 
manufacturer/distributor to keep the FDA informed of the cosmetics he has brought to the market 
(11). While the registration procedure is common to many countries, the fact that it is voluntary is a 
unique characteristic of the US and FDA.  
As stated before, manufacturers can also register through the VCRP, and inform the FDA of their 
activity, and this extends both to local and foreign manufacturers. Any manufacturer that has a 
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cosmetic product in the US market can be inspected at any given time if the FDA deems it 
appropriate with prior warning. Upon inspection, the manufacturer is expected to be able to prove 
that the conditions in which cosmetic products are produced assure quality and safety. Regarding 
GMP compliance, the FDA has published “Draft Guidance for Industry: Cosmetic Good 
Manufacturing Practices” (12), which was last reviewed in 2013. This guide was published and as a 
Draft, it is not compulsory to follow it, however, the FDA strongly encourages it and fully expects it 
to be adopted. 
With respect to assuring the safety of the cosmetic product for human health through its composition, 
the FD&C Act gives a definition in Section 361 of an Adulterated Cosmetic as that “which bears any 
poisonous or deleterious substance which may render it injurious to users under the conditions of 
use prescribed […] or are customary or usual”. This definition, in all its ambiguity will be used as a 
basis for ingredient regulation. A list of specific ingredients which are prohibited from being 
included into a cosmetic product has been issued by the FDA and is included in the Federal 
Regulations (13), but it is a small list, with only 12 items, in comparison to the ones established by 
the European Commission. Once again, the responsibility that the ingredients included are safe and 
that the labelling gives the appropriate indications lies solely on the person who has made the 
cosmetic available in the market, be it manufacturer, importer or brand. Nanomaterials can be used, 
but a full safety assessment is encouraged before its use. The FDA also encourages manufacturers to 
inform when using a new nanomaterial and to provide the scientific proof of its safety beforehand 
(14). 
In keeping with including enough information on the label about ingredients and the intended use of 
the cosmetic product, there are other pieces of information that need to be included. Failure to do so 
or to do it in an incorrect manner might render the cosmetic product “misbranded” according to the 
FD&C Act. A misbranded cosmetic is so when the “labelling is false or misleading in any 
particular”, or “if in package form unless it bears a label containing the name and place of business 
of the manufacturer, packer, or distributor, and an accurate statement of the quantity of the contents 
in terms of weight, measure or numerical count”. So here we have at least two requirements as to the 
content of the label: name and address and net content declaration, as well as a reference to any 
possible borderline claims. Furthermore, if we align both adulterated and misbranded definitions, we 
reach the conclusion that the label must also feature indications on the function/use instructions if 
deemed necessary and also any particular precautions regarding safety, whether it is because of an 
ingredient or the end product. Additional instructions are given as to the size and visibility of the 
label contents, which are not relevant to the current review. 
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Finally, on the subject of animal testing, the FDA does not support or condone the use of animals in 
order to test security or efficacy of cosmetics. It is once again left to the judgement and responsibility 
of the manufacturer/brand. It does insist that any testing required to ensure the safety of the cosmetic 
product must be used, while at the same time urging for alternative validated testing methods to be 
used. It also fully advocates for the use of the minimum animals needed to obtain the maximum 
amount of scientific information possible (15). 
As we have seen, there is much to be learnt from the differences between the US and the EU 
regulations. Differences like the consideration of certain products as cosmetics or drugs, the different 
approach to ingredient regulation and the like conform a template to which European products must 
adapt into in order to access the market. While the regulatory standpoint of the US might seem more 
relaxed than the one set by the EU Commission, the wording in the legal texts allows for the FDA to 
be able to implement any changes to the direction and standards without having to rework the basis. 
FDA guidelines serve as a departing point to understand the position it holds with some aspects such 
as labelling or GMP and allows better compliance from the industry. 
4.2.2. China 
In a similar way that the USA has an influence over western countries, so does China over Eastern 
hemisphere. It is arguably already one of the most powerful countries in the world, and this extends 
to the cosmetic industry. The increment of the cosmetic sector in China has impulsed the Eastern 
expansion of the cosmetic industry and also global growth. And it has done so despite the deep 
complexity of its regulatory framework. 
According to the definition given by the Chinese regulation, a cosmetic product is defined as “daily 
used industrial chemicals which can be spread on the outer surface of the human body (skin, hairs, 
nails, lips, etc.) for the purpose of cleaning, deodorizing, providing skin care, beauty and make-up, 
by way of smearing, spraying or other chemical means”2 (16). By this definition, both function and 
area of application are used to mark the confines of cosmetic products. By area of application, we 
can see that in the Chinese definition, teeth and oral mucous membranes are not included. Moreover, 
if we take a closer look we can appreciate the interpretation that has been given to the functions 
given. Similarly to the US regulation, the function of “protecting” is not included in this definition. 
However, there is an indication of “providing skin care” which has a wide enough scope as to 
include to protect or to aid with skin integrity, which would take it closer to the EU Regulation. The 
2 Not an official translation, extracted from CIRS-REACH 
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Chinese FDA (CFDA) has cleared the water on this matter by classifying cosmetic products into two 
clearly defined categories, which are: 
- General use cosmetics: general cosmetics are those used for hair care, nail care, skin care, 
perfumes and make-up. They are simple in the method of application and do not pose much risk 
for the consumers’ health. 
- Special-use cosmetics: including hair growth restoratives, hair dyes, deodorants and sunscreen 
products. These cosmetics have been categorized separately due to the increased complexity of 
their claims and properties, which need to be addressed and confirmed. They might also have a 
higher risk for human health under normal use conditions that warrants a strict control over them. 
So instead of categorizing more complex products as OTC drugs like the US FDA, the Chinese 
regulation assimilates these into the cosmetic definition. Yet it still acknowledges that they are to be 
carefully supervised. This in turn leads to differences in the kind of control the CFDA takes on each 
category. 
The process followed for the placement of a cosmetic product on the Chinese market will depend on 
the category of cosmetic it fits into. Two separate procedures will need to be completed if the 
product is to be authorised. Depending on the sources these processes might have different names, 
but what remains is that they are clearly distinct. General-use or non-special-use cosmetics have to 
be submitted for a registration process3 , sometimes referred as a notification due to its comparative 
simplicity. This registration entails the presentation of a dossier in which special attention is given to 
the labelling and the formula of the cosmetic product, to ensure that it has been rightly categorized as 
a general cosmetic. This registration is, as stated before, comparatively simple to the process through 
which special-use cosmetics are authorised and the time to complete the registration is also shorter. 
On the other hand, for special-use cosmetics, the process of product legalization is an “administrative 
authorisation”4. This procedure is more time-consuming and the main difference is that safety and 
claim proof has to be submitted and reviewed in order to assess the possible health risks and 
truthfulness behind the more complex claims (17). 
Regardless of the kind of product legalization that has to be undergone, the product formula will 
have to be submitted for reviewing. In China, cosmetic composition is regulated through a positive 
list, which is to say a list of ingredients that are allowed to be used in cosmetic formulations. This list 
is called the “Inventory of Existing Cosmetic Ingredients in China” or IECIC (18). In its last edition, 
3 This is a translation of the official name given as per the form document of request for registration. 
4 Again, the translation is directly extracted from the form of request for administrative authorisation. 
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2014, the IECIC included 8783 cosmetic ingredients approved by the CFDA. Alongside the cosmetic 
ingredients, for some a Maximum Use Concentration in Approved Product – or MUCAP- is given. 
The MUCAP represents the highest concentration of the ingredient available in the market through 
authorisation of the cosmetic product that contains it, and is not in itself a restriction. However, 
presence of an existing ingredient in a higher concentration than previously allowed must be 
accompanied with enough scientific data so as to ensure safety. Additionally, a cosmetic ingredient 
not listed in the IECIC means it has not been previously approved and must be submitted for 
ingredient registration with the CFDA, a process that can take up to two years (19).   
The list of ingredients, along with other information regarding the cosmetic product, has been set as 
requirements for the cosmetic product labelling according to the corresponding standard, 
GB5296.3/2008 General labelling for cosmetics (20). These have been included in the comparative 
table and do not introduce any new requisite. 
For manufacturers of cosmetic products, a regulation has been set in place in order to establish the 
correct production methods which need to be followed. The “Hygienic Standard for Production 
Enterprises of Cosmetics” (2007) (21) is an executive document containing GMP-like guidance to 
the manufacturer in order to ensure the sanitary conditions of cosmetic production. 
Lastly, we come upon the controversial and difficult topic of animal testing. It is on this topic that 
presents most difficulties for European exporters wishing to access the Chinese market. We have 
seen that the EU Commission banned animal testing both for ingredients or finished cosmetics 
products. China’s regulatory stance on this subject is the complete opposite, animal testing is not 
only acknowledged, but compulsory. The CFDA does not recognise alternative methods to animal 
testing and although this is slowly changing, the current stand remains the same. For cosmetic 
products being imported into China, both general-use and special-use cosmetics need to be tested on 
animals in order to receive approval (19). For Chinese manufacturers, only recently was the animal 
testing waived for general-use cosmetics, but not banned. The animal testing requirement enters in 
direct conflict with the EU Regulation 1223/2009 in which animal testing is banned for cosmetics 
sold in Europe. So, the same cosmetic product would initially not be able to be sold simultaneously 
in Europe and China. In order to circumvent this issue, the industry has had to come up with adroit 
solutions such as changing the product formula or name, so it is no longer the same cosmetic 
product, or import bulk product which will then be reprocessed in China and would be considered as 
a local cosmetic product and not subject to the animal testing requirement.  
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All in all, China offers an interesting third perspective into the cosmetic regulations. With a 
categorization of cosmetics into two groups, which is a system followed in many Asian countries, a 
perspective in product control that is interestingly complex and a stand on animal testing that offers 
enough of a challenge for foreign manufacturers.  
4.2.3. Saudi Arabia 
As a one of the most influential members of the Gulf Cooperation Council (GCC), and as a 
representative country of the Middle-Eastern community to which it belongs, Saudi Arabia is a 
sensible choice to bring into the comparison. 
The regulatory framework of cosmetic products in Saudi Arabia is mediated through two different 
and interrelating standards. On the one side, we have the Gulf Standard GSO1943/2009 and on the 
other the Saudi Standards or SASO 1953. The Saudi health authorities, in the form of the Saudi Food 
and Drug Administration (SFDA) gives prevalence to SASO Standards, but sanctions GSO 
1943/2009 (22). As in most of the middle-Eastern countries, Saudi Arabia includes the old European 
Directive 76/768/EEC as reference material (23). This directive has been openly acknowledged as an 
accepted regulatory text in some cases and when not, it has heavily influenced the local legislation. 
Within the SASO 1953 standard, a cosmetic product is defined as “any substance or preparation 
intended to be placed in contact with the various external parts of the human body (epidermis, hair 
system, nails, lips, and external genital organs) or with the teeth and the mucous membranes of the 
oral cavity with a view exclusively or mainly to cleaning them, perfuming them, changing their 
appearance and/or protecting them or keeping them in good condition” (23).  This definition, which 
is also given in the GSO standard, is completely in line with the one in the European Directive, 
which means that the type classification will also correspond with the one held in Europe. However, 
just like with the European Directive, and the later Regulation, this definition sets it apart from that 
given in China or the US. 
With regards to product control, up to 2015, while local businesses had to register with the SFDA, 
products manufactured locally did not need to be registered or follow and approval system. For 
imported cosmetics, a Conformity Assessment Program (CAP) was set into place so as to verify that 
the products conform to the given standards. For the CAP, private certification agencies have been 
given the right to issue certificates ensuring said compliance, and these can be obtained within the 
country of origin in order to speed up customs procedures.  From 2015, a notification scheme has 
been launched from the SFDA (24) into which all products and manufacturers/distributor must be 
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included. This notification also constitutes a marketing authorisation, as the SFDA verifies the data 
submitted and issues a response that fits into the accept/reject kind. Foreign cosmetic products being 
imported into Saudi Arabia and the corresponding foreign manufacturers also have to be notified 
through the same system. 
Among the items included in the Conformity Assessment and the notification process is the formula 
of the cosmetic product. The composition of cosmetic products is outlined by the corresponding 
annexes to the standard that include an adapted version of the ingredient lists included in the old EU 
Directive, in which only a few changes have been made. These changes can be found in importation 
guides published by the SFDA. In addition to these, and common to most of the Islamic world, there 
is a total ban on any kind of product containing lard or any kind of pork derivative. Furthermore, 
even if there is not particular restriction on alcohol concentration, in keeping with the Muslim 
tradition there are specific requirements for products containing this ingredient.  
Labelling requirements are in themselves not very different from the ones that have been examined 
before, with the main components being the same as we have seen for the European Union and 
China, for example. A specific indication of the allowed or expected languages is included in the 
Standard in which it states that certain aspects of the label can be in English, while others must be in 
Arabic. For product labelling regarding composition, there is a specific standard that deals with the 
particularities of cosmetics products containing alcohol within an Islamic environment. This standard 
is the SASO 585/2000 (25), which can be summed up as the inclusion of two indications that must 
appear clearly on the label. Firstly, an indication of the alcohol concentration in the finished product 
must be given. Secondly, precautionary statements must be included such as “not suitable for 
drinking” or “external use only” and these must appear in Arabic so as to reach the end consumer. 
Continuing, the SFDA has not published a corresponding guide of GMP for the cosmetic industry. It 
relies solely on the adaptation to the international standards of quality manufacturing. For domestic 
manufacturers, it is not clear from a regulatory point of view how GMP assessment is done, although 
there is a corresponding section within the notification scheme. However, for foreign manufacturers 
importing cosmetic products into the country it is done thought the Conformity Assessment Program, 
in which manufacturers are asked to submit any relevant documents regarding GMP and quality 
systems implementation or observance, be it in form of a declaration or an actual certification. 
Lastly, considering the subject of animal testing of cosmetic products and ingredients, there is no 
official position regarding to it which in itself constitutes a standpoint. Product safety must be 
guaranteed, without mention of the testing methods that must be followed. For cosmetic products 
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being imported into the country, all data regarding animal testing must be submitted for review, thus 
seeming of certain relevance at the very least, even if it is through external companies that are a part 
of the CAP. 
While Saudi Arabia does not introduce great changes from a regulatory point of view, it is still 
relevant to this review as a window into the regulations on cosmetics in the Middle East. It is true 
that it relies heavily on the European Directive 76/768 and to some extent, by some other 
international standards that are commonly accepted as progressive. But despite this, the standards 
have been adapted to suit the specific needs of the Islamic community. Neighbouring countries have 
also adapted following Saudi Arabia’s example and through the GSO Standards. The information 
reviewed in this section might be easily applicable to other Middle Eastern countries. 
4.2.4. Colombia 
The Andean Community (Comunidad Andina de Naciones or CAN) is a customs union that includes 
four countries: Colombia, Peru, Bolivia and Ecuador. Among the specific aims of a customs union is 
the promotion and aid of the establishing of trade relations between all countries included. In this 
line, it is in the union’s best interest to circumvent any possible technical barriers to trade. These 
countries have all set a common standard which they have all later transposed into their own legal 
framework. This gives an added value to this overview, as we not only gain sight of the Colombian 
industry, but also into the standard followed by several countries. We will also get a very general 
perspective, within all of its diversity, of what South America is like from a regulatory perspective. 
As mentioned, Colombia follows the CAN Standards which have been adopted into its own 
regulatory setting.  For cosmetic products, the corresponding standard is CAN Decision 516 (26), 
with its amendments: Decision 777 (27) and Resolutions 797 (28) and 1333 (29). Within Colombia, 
as well as the transposition of the standard, certain aspects have been further defined through local 
legislative actions, for example, Resolution 3132 (30) deals with specifics regarding sunscreen 
products, or Resolution 3774 (31) by which the CAN GMP guide has been accepted. 
The Andean Standard, Decision 516, defines a cosmetic as “any substance or formulation for local 
application intended for use on the different superficial areas of the human body: epidermis, hair, 
nails, lips and external genital organs or on the teeth or mucous membranes, with the aim to clean, 
perfume, change appearance, protect or maintain them in good condition and prevent or correct 
body odours”. This definition does not introduce any changes with respect of the European Directive. 
Products considered cosmetics in Europe would also be included in this category within Colombia, 
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and there is a list of corresponding product categories into which these products might be classified. 
As it is in line with the European definition, it is also significantly different from the definitions we 
have seen were given in China or US. 
Once defined the limits of a cosmetic product, the Decision also establishes the method for product 
and market control. In a similar way to the European Regulation, this procedure is also called a 
notification. But unlike the European model, in which the product is notified but there is no need for 
approval from the corresponding authorities, the CAN and Colombian compulsory notification will 
have an administrative decision of authorisation of the product. This notification process is called 
Compulsory Health Notification (Notificación Sanitaria Obligatoria or NSO). Each CAN country 
establishes the way the NSO takes place, and in Colombia, Circular 100-00439 sets the validity of 
this Notification for a period of 10 years (32). In order to complete the NSO, an official form must be 
completed and the relevant information requested by the health authorities must be attached, 
including relevant information regarding claims of the product, product formula, safety evaluation, 
or production method description within the scope of GMP. Product notification is not centralized as 
it is in the European setting, but consistent with the common standard, there is a process of product 
notification recognition. This recognition process is based in a trust setting between health authorities 
of the member states. The request for product notification recognition is also form-based, but the 
amount of information to be included is significantly less.  
Product formula is also assessed as part of the notification process before been given the 
authorisation to place the product on the market. The CAN standard, and hence the Colombian 
regulations, have decided against directly including any list into the legal text. Instead, the official 
acknowledgment of international standards has been adopted as the best method of ingredient 
control. Thus, Article 3 of the Decision 516 recognises the following ingredient lists: US FDA, 
CTFA (Cosmetics, Toiletry & Fragance Association), Cosmetics Europe and the European 
Directives.  This is, in a way, a comfortable approach to control the ingredients being used in 
cosmetic products. The acceptance of international standards profits from scientific and 
administrative contributions of other countries. With this, new recommendations or limits for 
ingredients that might have a health risk are incorporated as soon as these changes are set into the 
corresponding international lists. Secondly, there is no need to be constantly reviewing and updating 
the published lists, which can be time-saving and allows for an agile way to stay on top of human 
safety conditions. 
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As for labelling requirements, again, there is no significant change with respect to the items to 
include according to the European Directive, the Chinese regulation or the Saudi Standards. Items 
like the name and address of the manufacturer or person responsible for its marketing and particular 
precautions that the consumer must be informed about have to be included. The language of choice is 
Spanish, and all precautionary text or instructions must be included at least in this language. There is 
one different item to be incorporated which is exclusive to the Andean Standard and that is the NSO 
number. Each time a notification is submitted and approved, the product is assigned a unique code 
into which the initials of the country of first market entry are included. This code must be placed on 
the product label and is one more element that helps in the in-market control of the cosmetic product. 
One other element that has been incorporated into the Colombian regulatory setting is the 
compliance with GMP methods of production. Control over GMP implementation is accomplished 
through the operating licence that local manufacturers or distributers need to obtain in order to be 
able to produce cosmetic products. Through Resolution 3774, Colombia encompasses the GMP 
standards issued by CAN and includes it into their own requirements. INVIMA, which is the 
corresponding health authority in Colombia, upon request to register a cosmetic production facility, 
would perform an on-site inspection to guarantee that the minimum hygienic standards are being 
met.  
Animal testing restrictions have not been included into the regulatory framework neither in 
Colombia nor the CAN. This, like in Saudi Arabia, implies that it is not necessarily a requirement to 
assuring product safety, but it is not banned either and as such it can be used to determine the health 
risk the cosmetic product might pose. 
Without any considerable addition to the global framework, we see here how Colombia and CAN 
adapt international standards into their own regulatory setting, with big reliance on the European 
Directive and acceptance of other relevant standards. 
4.2.5. The Philippines 
The last country to be reviewed in this international comparison is the Philippines, which has been 
chosen as a representative selection of the countries that together form the ASEAN. The ASEAN or 
Association of Southeast Asian Nations is a political and economic organization similar to the 
European Community. Among the member states are the Philippines, Indonesia, Malaysia, 
Singapore, Thailand and Vietnam. All these countries have adopted a common standard in order to, 
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like in the case of the EU and CAN, allow for a smoother trade and movement of cosmetic products 
through their borders.  
The ASEAN Directive, which is currently in its 4th amendment, is another instance of a regulatory 
text heavily influenced by the European Directive (33). We can find overwhelming proof of this in 
the very first element we have been comparing, the definition of a cosmetic product. According to 
the ASEAN definition, a cosmetic is “any substance or preparation intended to be placed in contact 
with the various external parts of the human body (epidermis, hair system, nails, lips and external 
genital organs) or with the teeth and the mucous membranes of the oral cavity with a view 
exclusively or mainly to cleaning them, perfuming them, changing their appearance and/or 
correcting body odours and/or correcting them or keeping them in good condition”. This stated 
definition is almost word-for-word the European definition of a cosmetic product. So, in the ASEAN 
countries, products are clearly defined as Cosmetics or drugs, with no double or borderline products. 
Once established the scope of a cosmetic product, the ASEAN lays down the bases for product 
control. Like in many other countries of the world, as we have seen done before for cosmetic 
products under several standards, cosmetic products must be notified to the relevant authorities. 
Within the Philippines, this control is exercised by the corresponding FDA However, as with the 
CAN standards, the notification system is also a method of product approval, in which there is 
administrative response as to whether the product conforms to the required standards or not. There is 
also a recognition system in place for the notification in all the member states of the ASEAN 
community, through which product approval may be granted for market access in more than one 
country. 
As per usual, the product formula is one of the most relevant pieces of information when submitting 
the cosmetic notification to the health authorities. Cosmetic ingredients are once again directly 
derived from the European Directive. So much so that Article 4 of the Directive bears the following 
sentence: “Member States shall adopt the Cosmetic Ingredient Listings of the EU Cosmetic Directive 
76/768/EEC including the latest amendments”. Following this statement is a complete review of the 
ingredient annexes that are to be used or prohibited in cosmetic products. As we have seen before, 
this is allows for easy and effective ingredient listing and update without the need for a constant 
revision and modification of the text. 
Product labelling is another unsurprising part of the ASEAN Directive; it has no new elements to be 
included in the cosmetic label. All elements that are to be included have been mentioned in other 
regulatory texts we have reviewed before. However, if we are looking for an element to difference it 
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from the others, it might be the extensive lists that the Philippine FDA has published of particular 
precautions that must be included depending on the type of cosmetic product and for some specific 
ingredients (34) (35). In its last amendment of the ASEAN Directive, a special precautionary 
message is advised to be included on sunscreen products. 
As far as GMP implementation in production facilities for cosmetics goes, the ASEAN has published 
within its Directive a GMP guide to be followed (33). The way in which the authorities supervise the 
production of cosmetic products in hygienic conditions is through a manufacturing authorisation or 
warehousing operations authorisation in which an inspection takes place to ensure that minimum 
requirements are being met. The Philippine FDA in an effort to help local manufacturers comply 
with ASEAN GMP standards has published a small guidance documents in which common questions 
posed by the industry are answered (36). 
Finally, the Philippine FDA and the ASEAN community have not issued any kind of legal ban or 
statement neither condoning nor allowing testing on animals for cosmetic ingredients and products. 
With the deep reliance there is from the ASEAN directive on the European legislation, great efforts 
have been made in order to ensure full homogenisation. A meeting has taken place between ASEAN 
Heads of Delegation and animal-rights activists in order to formally ask for the introduction of a ban 
on animal testing. So far, Vietnam is the best supporter of this cause and has agreed to introduce a 
program to boost valid alternatives (37). 
Vietnam, where animal testing was openly conducted, has recently agreed to meet with animal 
activist groups whose aims are to stop animal testing. 
5. A COMPARATIVE CONCLUSION 
We have seen here a total of six examples of regulatory frameworks that are current and in force at 
the moment of this review and one that has already been derogated and replaced. With them we have 
covered a big part of the world’s legislative bases and examined good and valid examples of 
different aspects included in the laws that control and limit the cosmetic industry. Tables 1 and 2 
contain a summarised compilation of the differences and similarities in the elements that have been 
reviewed. For a few of these elements it is worth drawing a final line in order to better make a point. 
Product classification is a major issue when dealing with different regulations and countries. What is 
a cosmetic in one place might be a drug in another or a borderline product in yet another. This is 
better explained through Figure 1. We have seen how the European Directive clearly makes this 
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separation, so that there are two related but clearly separate categories: drugs and cosmetics. This 
maintains continuity in that no product is left unclassified, and there are no borderline products; it is 
always a cosmetic or a drug. In contrast, in the United States, under the FDA definition, there is a 
certain degree of overlap in product categories. A product can be clearly a cosmetic, clearly a drug, 
or be both at the same time, like we have seen for sunscreen products. The third kind of product 
classification entails the addition of a new category as a bridge between a cosmetic and a drug. A 
general cosmetic product will have basic properties, functions and claims. A special-use cosmetic 
will have some kind of function or claim that makes it more susceptible to present a health risk, 
while a drug will have its own set of characteristics. There is also continuity, but distinguishing a 
general cosmetic from a special-use cosmetic can sometimes be just a matter or a sentence on the 
label. 
 
Another possible source of confusion is product control. There are a set number of product control 
processes from the authorities, and a set number of names, but the combinations of both used are 
plentiful. Products can be freely manufactured and sold, they may have to be communicated the 
authorities of their intended production/commercialisation or they may need to apply for an 
authorisation on the cosmetic product. These are the three possibilities to which product control is 
limited. Confusion derives when the term “notification” is used in any other meaning than the 
communication to the authorities, and “registration” is not used to indicate product approval. Europe 
and China are examples of well used terms, in that in Europe you notify the cosmetic product but the 
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product is not approved or rejected, and in China the product must be registered in a process that 
involves product and information review. For CAN and ASEAN directives, the term notification is 
used probably to set it aside from a typical registration procedure which is usually long and 
complicated, but even a simplified registration is not the same as a notification while it still needs an 
administrative response. 
The next three elements, ingredients, labelling and GMP, do not present much room for confusion. 
European composition lists are exhaustive, while US is in contrast quite thrifty, leaving ample room 
to move around in, and China is in itself quite restrictive as new ingredients have to be registered too. 
Labelling requirements do not vary that much, leaving the same information to be added in all 
countries, with language variations and certain particularities, such as alcohol information in Saudi 
Arabia. For GMP, all regulatory texts agree that product safety is the main concern and reflect that in 
the publishing or acceptance of a GMP Standard. It is understood that for a product to be safe it 
needs to be manufactured in adequate and hygienic conditions. However, there does not seem to be 
any kind of consensus as to how these GMP are verified. In Europe, ISO 22716 is in force as the 
standard, but there is no requirement for certification and the authorities do not always inspect for 
compliance. In other countries, a licence of operations must be obtained for which inspections are 
carried out in order to assure GMP compliance before the manufacturer begins commercial activity. 
Finally, animal testing is an important topic from a legal and ethical point of view. Europe has 
proved that the cosmetic industry can be safe without the use of animals for testing, and opting 
instead for in-vitro methods. This has convinced other countries to join in and also ban animal 
testing, two of the latest being India and New Zealand. However, while most countries lean towards 
the use of in vitro alternatives, they do not introduce a ban on animal testing and so it continues to be 
a common practice throughout the world, especially when considering the possibility of marketing in 
China. As we have seen, China’s regulation is in direct contrast to Europe’s, not recognising the 
validity of alternative tests and making animal testing a compulsory step in order to register cosmetic 
products.  While the interest for cruelty-free cosmetics increases, the authorities are more interested 
in introducing a ban also is at a rise, but to this moment, most of the regulatory world is still in 
neutral ground and will not take a step either way. 
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6. A PRACTICAL APPROACH 
Some things are better explained or seen through a practical example and this case is no different. 
This section aims to sum up some of the concepts that have been set and explained in the previous 
regulatory analysis and to show how changes in legislation apply to a real cosmetic product and not 
just the theory behind it.  
In order to undertake this practical approach, two cosmetic products have been selected, the first is a 
moisturizing cream and the second a sunscreen oil. These two products will be checked for 
compliance both within the European Union, for which they should be found correct as they are 
currently available in the market, and international compliance within the countries that have been 
examined. The products will remain unidentified throughout, but the main product characteristics 
have been detailed in Table 3.  
 
 
 
 
 
 
 
 
 
Now that we have the relevant information about the product we can move on to the compliance 
verification. This will be done in three stages of verification: product type and control, composition 
and labelling. These three elements constitute the first barriers when exporting cosmetic products, 
and the first stage in ensuring product conformity 
In order to introduce a cosmetic product into a foreign market, most countries and authorities expect 
and regulate cosmetic products before they can be accessible to the end consumer. As it has been 
shown before, these processes are usually named “registration” or “notification”. The information on 
product control for each of the two products is reflected in Table 4 of Annex I. It is apparent from the 
Table 3. Descriptive table of the two compared cosmetic products. 
PRODUCT TYPE Oil-free moisturiser Dry oil sunscreen SPF20 
PRESENTATION Plastic tube with screw-on lid, 50ml Plastic bottle with spray, 200ml 
INGREDIENTS Detailed in Composition Review Detailed in Composition Review 
LABEL 
CONTENTS 
- Name of product and brand 
- Function 
- Ingredients 
- PAO 
- Net content 
- Directions for use 
- Cautionary messages 
- Product Claims 
- Country of Origin 
- Name and address of the responsible 
person 
- Name of product and brand. 
- SPF indication 
- Net contents 
- Method of use 
- Cautionary messages 
- PAO 
- Product Claims 
- Name and address of the 
responsible person 
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table which regulations segregate cosmetics into more than one kind of products and what that means 
in regards to product control. It exemplifies the relationship between a cosmetic product in the 
broader sense, between a general-use cosmetic and a special-use cosmetic, and between a cosmetic 
and a drug. 
Further, Table 5, also in Annex I, contains the identification of the cosmetic composition. The 
qualitative formula of the oil-free moisturiser has been included and contrasted against the existing 
composition lists in the corresponding countries to look for non-compliant ingredients. Since there is 
no quantitative data as to the concentration of each ingredient, we will base the analysis on a three-
colour indicator. A green indicator  means the cosmetic ingredient is free to use in any concentration. 
An exception to this will be made in China’s revision, in which the cosmetic ingredient is sometimes 
approved for use giving a MUCAP value. If the presence of this ingredient is above the MUCAP 
value, a new registration for cosmetic ingredient must be presented before registering the cosmetic. 
For China, a green indicator has been given to those ingredients without a MUCAP value or which 
the MUCAP value is well above the concentration used normally in cosmetics.  For all countries, a 
yellow indicator will mean a cosmetic ingredient that has a certain restriction, but we will not be 
studying the particular restrictions that have been laid down. A red indicator will be for a prohibited 
ingredient present in the formulation. Also collected in Table 5 is the function of the cosmetic 
ingredient, which will give us an idea of the reason behind the presence of the ingredient and also 
hint at the reasons behind the restriction that may have been put in place. It is very likely that a 
preservative will have a restriction in place, while a solvent will be accepted at most concentrations. 
Also, for multi-purpose ingredients, restrictions might be in force for one of the uses, but not for the 
rest. 
Finally, Table 6 contains the information included in the Dry Sun Oil SPF20. The items that are 
present have been arranged also into a compliance-checklist. Again, a green indicator means a 
certain item is found to be compliant, as it is with most of them. Yellow indicators have been given 
to those items which need special attention, in particular, the name and address of the responsible 
person, while present, must change from one country to another as the local authorities will only 
recognise a responsible person within the limits of their jurisdiction or country. Also, there is no 
indication of the country of origin, which is not in itself a non-compliance if it is not an imported 
cosmetic. However, if this cosmetic were to be exported, it should be included. A red indicator has 
been given to two specific items in three countries. Being an alcohol-based product, it should bare a 
special indication of the concentration for Saudi Arabia. In China and Colombia, the labelling has to 
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include the number assigned to the cosmetic as a result of the respective registration/notification 
process. 
7. FINAL CONCLUSIONS AND THEME INTEGRATION 
Throughout this review there has been a conscious effort to scale down a subject which is far from 
being brief, and all the effort has been put into being able to provide a wide vision of what the global 
scheme of regulations that affect directly or indirectly all cosmetic products. We move in a 
globalised world where little attention is sometimes given to what it takes to move things across the 
planet. We have seen how China demands animal testing which invalidates a product for European 
commercialization, where these practices are banned. We have also seen how a product might have 
to be registered in the USA if it contains a sunscreen ingredient even if it is not the product’s primary 
claim to protect against sunburns. And yet there are a lot of subjects which have had to be set aside 
in order to reduce the scale of analysis, such as product claims which are another big issue within the 
cosmetic industry, or toxicological/safety assurance testing. Additionally, a practical example was 
given in order to illustrate many of the points which were exposed during the review and to bring 
home the conclusion that, while many items of the regulations and laws are similar, there are still 
those which remain different and open the door to possible non-compliances. 
The subject of the review has been specific, a law is a law after all, and it is mainly based in the 
abilities and competences derived from the Legislation and Deontology scope. However, there is a 
background theme that carries along the review which is related to the Pharmaceutical Management 
area. After all, the direct application of the analysis of these laws correlates perfectly with the private 
sector and cosmetic industry, both with its merits and challenges. Furthermore, there is the need for 
regulatory experts to work hand in hand with all the areas of the industry, either with research in 
order to determine the allowed composition,  with the design team in order to design compliant 
labels or with the sales department to see which countries are available for distribution. Regulatory 
knowledge means little without the practical applications. Finally, by bringing the subjects of good 
manufacturing practices and the analysis of the function of the cosmetic ingredients, 
Pharmaceutical/Cosmetic Technology has been included as a present theme in several parts of the 
review. 
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ANNEX I. Product compliance  
Table 4. Product type and control in the different countries included in the review 
               Country  
Product type Europe USA China Saudi Arabia Colombia Philippines 
Oil-free 
moisturiser 
Compulsory product 
notification prior to 
commercial 
distribution, no 
approval needed 
Voluntary 
Notification after the 
product is placed in 
the market, no 
approval needed 
General cosmetic 
registration for 
product.  
Electronic notification 
and product 
verification through 
CAP. 
Obligatory product 
notification before 
product is placed in the 
market, approval must 
be granted. 
Product notification 
prior to product 
entering the market, 
approval must be 
granted. 
Dry oil sunscreen 
SPF20 (as above) 
OTC Drug Product 
Registration and 
Voluntary 
Notification. 
Special use cosmetic 
registration for 
product. 
(as above) (as above) (as above). 
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Table 5. Qualitative formula for oil-free moisturizer, including function of the ingredients and compliance checklist for each country. Countries are 
named according to the three letter code included in ISO 3166.  
INGREDIENT LIST FUNCTIONS EUR USA CHN SAU COL PHL 
Aqua Solvent             
Glycerin Humectant, Masking, Protection, Vistosity Control             
Propylene Glycol Humectant, Skin Conditioning, Solvent, Viscosity Control             
Cetyl alcohol Emollient, Emulsifier, Opacifyer, Surfactant, Viscosity Control             
C12-15 Alkyl Benzoate Emollient, Skin Conditioning, Antimicrobial             
Stearyl Alcohol Emollient, Emulsifier, Opacifying, Surfactant, Viscosity Control             
Glyceryl Stearate Emollient, Emulsifying             
PEG-100 Stearate Surfactant             
Salicylic acid  Keratolytic, Masking, Preservative, Skin Conditioning.             
Aloe Barbadensis Leaf Extract Emollient, Humectant, Skin Conditioning             
Chamomilla Recutita Extract Skin Conditioning             
Menthyl Lactate Masking, Refreshing             
Cetyl Lactate Emollient, Skin Conditioning             
Cocamidopropyl PG-Dimonium Chloride Phosphate Antistatic             
C12-15 Alkyl Lactate Emollient, Skin Conditioning             
Dimethicone Emollient, Skin Conditioning, Skin Protection, Antifoaming             
Sodium Isostearoyl Lactylate Cleansing, Emulsifying, Surfactant             
Propylene Glycol Isostearate Skin Conditioning, Surfactant             
Alcohol Denat Antimicrobial, Astringent, Solvent, Masking             
Isopropyl Alcohol Antifoaming, Perfuming, Solvent             
Myristyl Alcohol Emollient, Emulsion Stabiliser, Skin Conditioning, Viscosity 
Control 
            
Palmitic Acid Emollient, Emulsifying             
Stearic Acid Cleansing, Emulsifying, Surfactant, Emulsion Stabilizer             
Carbomer Emulsion Stabilising, Viscosity Controling             
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Acylates/C10-30 Alkyl Acrylate Crosspolymer Emuslion Stabilising, Film Forming, Viscosity Control             
Sodium Chloride Bulking, Masking, Viscosity Control             
Disodium EDTA Viscosity Controlling             
Sodium Hydroxide Buffering, Denaturant             
Lactic Acid Buffering, humectant, skind conditioning             
Benzalkonium Chloride Antimicrobial, antistatic, deodorant, preservative, surfactant             
Methylparaben preservative             
Propylparaben perfuming, preservative             
Ethylparaben preservative             
Phenoxyethanol preservative             
Parfum -             
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Table 6. Label for the Sunscreen Dry Oil SPF 20, including compliance checklist. Countries are named according to the three letter code included in 
ISO 3166. 
LABEL ITEM CONTENT EUR USA CHN SAU COL PHL 
Name of the product (Brand name) Dry Sun Oil       
Name and address of the responsible 
person 
Visible       
Nominal content 200mL       
Expiry date/ PAO PAO 12M       
Precautions “Excessive exposure to sun is dangerous to health. Keep babies 
and young children out of direct sunlight. Avoid contact with 
clothing- Avoid contact with eyes. Do not spray near a naked 
flame or any incandescent material. FLAMMABLE. 
CONTAINS ALCOHOL.” 
      
Batch number Present       
Function From presentation       
Ingredient list Present       
Country of Origin Not included       
Alcohol declaration content Not included       
Registration/Notification number Not included       
 
